Clinical trial
Control of Epidemic Influenza Through a School-based Influenza Vaccination…
NCT00138294 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00138294 |
|---|---|
| Title | Control of Epidemic Influenza Through a School-based Influenza Vaccination Program |
| Official title | Phase 4, School-based, Open-labeled Research Trial for Control of Epidemic Influenza Through a School-based Influenza Vaccination Program in Central Texas. |
| Acronym | CEI |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | Scott and White Hospital & Clinic Novartis Industry Sanofi Pasteur, a Sanofi Company National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | live attenuated and inactivated influenza vaccines |
| Enrollment | 29,255 |
| Start date | Oct 1, 1998 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Aug 30, 2005 |
| Last update posted | May 19, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: